secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wave Life Sciences Ltd. (WVE)
CIK:        0001631574
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001193125-25-178083
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wave Life Sciences shareholders approve 8M share increase to equity plan
------------------------------------------------------------------------

- Shareholders approved 8M share increase to 2021 Equity Incentive Plan (105.9M for, 24.6M against).
- All nine director nominees re-elected, including Paul Bolno and Christian Henry.
- KPMG ratified as independent auditor for FY2025 with 144.5M votes for.
- Advisory executive compensation vote passed with 129.6M for; shareholders favored annual frequency (130.2M for one-year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1631574/000119312525178083/0001193125-25-178083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1631574/000119312525178083/d35789d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-178083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer